Evidence map›Paper›PMID 32597628›Full record

ArticleACS chemical biology2020

Identifying the Target of an Antiparasitic Compound in

Alice L Herneisen, Saima M Sidik, Benedikt M Markus, David H Drewry, William J Zuercher, Sebastian Lourido

Open access · greenAbstract read
In one paragraph

Article in ACS chemical biology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
5.4field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 43 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Current and emerging target identification methods for novel antimalarials.International journal for parasitology. Drugs and drug resistance · 2022
    Review
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Chemoproteomics for Plasmodium Parasite Drug Target Discovery.Chembiochem : a European journal of chemical biology · 2021
    Review
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Alice L HerneisenDepartment of Biology, Massachusetts Institute of Technology, 30 Ames St, Cambridge, Massachusetts 02142, United States.
Saima M SidikWhitehead Institute for Biomedical Research, 455 Main St, Cambridge, Massachusetts 02142, United States.
Benedikt M MarkusWhitehead Institute for Biomedical Research, 455 Main St, Cambridge, Massachusetts 02142, United States.
David H DrewryStructural Genomics Consortium, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, United States.ORCID 0000-0001-5973-5798
William J ZuercherStructural Genomics Consortium, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, United States.ORCID 0000-0002-9836-0068
Sebastian LouridoDepartment of Biology, Massachusetts Institute of Technology, 30 Ames St, Cambridge, Massachusetts 02142, United States.ORCID 0000-0002-5237-1095
Whitehead Institute for Biomedical Research · USUniversity of North Carolina at Chapel Hill · USUniversity of Freiburg · DE

Funding

Control of parasite invasion by a microneme protein complex conserved in ApicomplexansR01AI144369 · NIAID · WHITEHEAD INSTITUTE FOR BIOMEDICAL RES · PI LOURIDO, SEBASTIAN · 2020 to 2024
$2.4M
NIAID NIH HHS R01 AI144369Wellcome TrustWellcome Trust 106169/ZZ14/Z
6 · The paper itself

Abstract

Apicomplexan parasites include the causative agents of malaria and toxoplasmosis. Cell-based screens in

Indexed as

Antiprotozoal AgentsCalcium SignalingImidazolesParasitic Sensitivity TestsProtein BindingProtein Kinase InhibitorsProtein KinasesProteomeProteomicsProtozoan ProteinsPyridinesToxoplasmaAntiprotozoal AgentsImidazolesProtein Kinase InhibitorsProtein KinasesProteomeProtozoan ProteinsPyridines

Identifiers

PMID32597628
PMCPMC7585386
OpenAlexW3037423588

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.